Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).Financial Summary - Second ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE